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The U.S. President’s Malaria 
Initiative 
The U.S. President’s Malaria Initiative (PMI) is a U.S. 
Government initiative established in 2005 to sharply 
decrease malaria deaths by scaling up proven 
interventions. PMI is an interagency initiative led by 
the U.S. Agency for International Development (USAID) 
and implemented together with the U.S. Centers for 
Disease Control and Prevention (CDC). PMI works in 19 
sub-Saharan Africa countries, where malaria exacts its 
greatest human toll, and the Greater Mekong Subregion, 
where resistance to the most effective malaria treatment 
drugs has already appeared. 
In each PMI country/region, two PMI resident advisors 
(one each from CDC and USAID), supported by other  
in-country staff and teams at CDC and USAID 
headquarters, work with host country governments  
to support implementation of national malaria control 
program (NMCP) plans. PMI teams develop annual 
malaria operational plans; participate in national malaria 
partner coordination mechanisms; and assist in the 
design, implementation, monitoring, and evaluation of 
program activities. 
Because of PMI and its global partners, more people  
than ever have access to life-saving malaria interventions. 
The World Health Organization (WHO) 2015 World 
Malaria Report documents that global intervention  
scale-up was associated with more than 6.8 million lives 
saved from 2000 through 2015.
CDC’s Major Contributions
For more than 60 years, CDC has provided scientific leadership  
in public health efforts to fight malaria, increasing global  
capacity to prevent death and illness from malaria. CDC helped 
develop and evaluate four key global malaria interventions: 
long-lasting insecticide-treated nets (ITNs), rapid tests to 
diagnose malaria and artemisinin-based combination therapies 
to treat malaria patients; intermittent preventive treatment for 
pregnant women; and indoor residual house spraying (IRS)—all 
recommended by WHO and supported by PMI. With PMI,  
CDC’s expertise in strategic science focuses on making sure 
these interventions remain effective and continue to save lives.
CDC continues its long history of collaboration with NMCPs, 
helping build their technical leadership and capacity to plan  
and implement effective prevention and control measures.
CDC’s Congressional Mandate in 
Support of PMI: Strategic Information 
CDC has been directed by the U.S. Congress to advise the 
U.S. Global Malaria Coordinator and play a leading role in the 
implementation of monitoring, surveillance, and evaluation 
activities for malaria. To ensure that limited resources are used 
wisely, CDC helps countries and the U.S. Government target 
appropriate malaria prevention and treatment efforts and 
understand the impact of PMI efforts.
Evaluating Impact
CDC provides scientific expertise in evaluating the health 
impacts of malaria control interventions in PMI-supported 
countries in sub-Saharan Africa, in collaboration with national 
and global partners. Impact evaluations have been completed  
in seven PMI countries and are underway in an additional six. 
These impact evaluations have linked improvements in child 
survival and reductions in malaria transmission to the expansion 
of malaria control activities—findings that have been mirrored in 
national household surveys. For example, in Malawi and Rwanda, 
deaths in children under the age of 5 years have declined by 
30% and 67%, respectively, over the last decade. PMI resident 
advisors based in countries where malaria is endemic play a 
critical role in these evaluations and help train host country 
counterparts to become leaders in research and evaluation 
science. CDC scientists and program managers also assist NMCPs 
and partners in disseminating evaluation findings at national 
and international policy and scientific meetings.
Insecticide-treated 
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Pyrethroid Resistance in PMI Countries
PMI monitors mosquitoes’ resistance to insecticides, which 
ITNs and IRS rely on for preventing malaria transmission. 
When resistance to one class of insecticide is detected, 
changing to a different insecticide is required for IRS to 
remain effective.
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Monitoring Interventions through 
Surveillance
CDC’s malaria epidemiologists, entomologists, laboratorians,  
and public health advisors provide internationally recognized 
expertise to help ensure that PMI-funded interventions  
continue to provide protection against malaria and save lives.  
For example, mosquitoes that transmit malaria may develop 
resistance to the insecticides used on bed nets or applied  
to walls of households. Likewise, malaria parasites can  
gradually develop resistance to antimalarial drugs. CDC supports 
NMCP partners to remain vigilant against emerging insecticide 
and anti-malarial drug resistance. 
Surveillance for confirmed malaria cases, another cornerstone  
of CDC expertise, is key. Improved systems to capture, transmit, 
analyze, and disseminate malaria surveillance data in a timely 
manner will help hone strategic approaches as malaria continues 
to decline. This combination of monitoring (vector – parasite – 
human) in each PMI country provides necessary data to trigger 
programmatic decisions regarding insecticide use, malaria 
treatment policy, and optimal deployment of program resources 
so that program activities can be continuously adjusted for 
maximum effectiveness. 
Optimizing Interventions via  
Operational Research
Following the broad scale-up of proven public health 
interventions, questions are often raised about  
how to maximize impact of a particular intervention by  
making it even more effective, more acceptable, more accessible, 
or more economical. CDC experts identify operational research 
opportunities within PMI countries and implement studies to 
strengthen and refine malaria control strategies. For example, 
when variation in physical durability of ITNs was first observed 
several years ago, CDC initiated efforts to study net longevity 
in eight PMI countries. Results of these studies helped identify 
weaknesses in some net brands, and in one case a manufacturer 
modified its net construction to improve the longevity of ITNs 
procured by PMI. They have also played a key role in helping WHO 
formulate recommendations for net monitoring. CDC’s scientific 
leadership and global network of collaborators help partner 
countries to conceive, implement, and evaluate malaria control 
programs—and to produce results that can be used to guide the 
allocation of PMI resources. 
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